Business|Finance|Health
Weight-loss drug powers Lilly results, 2024 forecast raised by $3 billion
Increased manufacturing capacity for Eli Lilly's highly sought after weight-loss drug Zepbound drove the company to raise its annual sales forecast by
August 08, 2024